Abbott to acquire Cardiovascular Systems for $890 million
Abbott Laboratories has agreed to buy medical device maker Cardiovascular Systems for about $890 million.
Drugs
Pharma
Abbott Laboratories has agreed to buy medical device maker Cardiovascular Systems for about $890 million.